Meyler's Side Effects of Drugs in Cancer and Immunology

Buch | Hardcover

780 Seiten

2010
Elsevier Science Ltd (Verlag)
978-0-444-53267-1 (ISBN)

Artikel merken

Suitable for oncologists and cancer researchers, this work helps to determine effective drug treatments. It features not only anticancer drugs, but also other drugs that act upon related organ systems affected by cancer.

Elsevier now offers a series of derivative works based on the acclaimed Meyler’s Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician.

There has been significant progress in the development of targeted therapy drugs that act specifically on certain cancers, and that minimize damage to normal cells. Oncologists and cancer researchers will rely on this volume to determine effective drug treatments.

Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK’s National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.

Erscheint lt. Verlag	19.4.2010
Verlagsort	Oxford
Sprache	englisch
Maße	216 x 276 mm
Gewicht	2070 g
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie
	Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie
	Medizin / Pharmazie ► Pharmazie
ISBN-10	0-444-53267-6 / 0444532676
ISBN-13	978-0-444-53267-1 / 9780444532671
Zustand	Neuware